LAWSUITS FILED AGAINST BIRD, TSE and FULC - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / May 25, 2023 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Allbirds, Inc. (NASDAQ:BIRD)

CONTACT JAKUBOWITZ ABOUT BIRD:
https://claimyourloss.com/securities/allbirds-class-action-loss-submission-form/?id=39963&from=1

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Allbirds Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's November 2021 initial public offering; and/or (b) Allbirds securities between November 4, 2021 and March 9, 2023, inclusive.

Lead Plaintiff Deadline : June 12, 2023

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Allbirds was overemphasizing products that extended beyond the Company's core offerings; (2) the Company's non-core products had a narrower appeal and were not resonating with customers as well as the Company's core products; (3) Allbirds was underinvesting in its core consumers' favorite products to push the Company's newer products with narrower appeal; (4) underinvesting in Allbirds' core products was negatively impacting the Company's sales; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Trinseo PLC (NYSE:TSE)

CONTACT JAKUBOWITZ ABOUT TSE:
https://claimyourloss.com/securities/trinseo-plc-class-action-loss-submission-form/?id=39963&from=1

Class Period : May 3, 2021 - March 27, 2023

Lead Plaintiff Deadline : June 20, 2023

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's Bristol, Pennsylvania plant had a troubled safety record while under prior ownership and continued to be unsafe after the Company acquired it; (2) defendants did not sufficiently disclose specific risks related to conducting operations at that plant; (3) operating a chemical plant with an unsafe history and presently unsafe operations exposed the Company to a heightened risk of a chemical spill or other adverse events; and (4) as a result, defendants statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

Fulcrum Therapeutics, Inc. (NASDAQ:FULC)

CONTACT JAKUBOWITZ ABOUT FULC:
https://claimyourloss.com/securities/fulcrum-class-action-loss-submission-form/?id=39963&from=1

Class Period : March 3, 2022 - March 8, 2023

Lead Plaintiff Deadline : June 27, 2023

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887

SOURCE: Jakubowitz Law

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.